Advanced search
Publication Cover
Cytokines, Cellular & Molecular Therapy Volume 7, 2002 - Issue 1
Journal homepage
3
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Amino acids 67 and 68 of transforming growth factor-β regulate binding to a glycosyl phosphatidyl inositol-linked membrane protein on vascular endothelial cells

Kai-Qi Zhang Marshfield Medical Research Foundation, 1000 North Oak Avenue, Marshfield, WI, USA
,
David Polga Marshfield Medical Research Foundation, 1000 North Oak Avenue, Marshfield, WI, USA
,
Sherry Salzman Marshfield Medical Research Foundation, 1000 North Oak Avenue, Marshfield, WI, USA
&
James Burmester Marshfield Medical Research Foundation, 1000 North Oak Avenue, Marshfield, WI, USA
Pages 25-30 | Published online: 26 Sep 2009

  • Moses HL, Yang EY, Pietenpol JA, TGF-ß stimulation and inhibition of cell proliferation: new mechanistic insights. Cell (1990) 63: 245-7.
  • Roberts AB, Sporn MB, Physiological actions and clinical applications of transforming growth factor-ß (TGF-ß). Growth Factors (1993) 8: 1-9.
  • Massagué J, The transforming growth factor-ß family. Annu Rev Cell Biol (1990) 6: 597-641.
  • Isaka Y, Bret-s DK, Ikegaya K et al, Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med (1996) 2: 418-23.
  • Khalil N, Greenberg AH, The role of TGF-ß in pulmonary fibrosis. Ciba Found Symp (1991) 157: 194-207.
  • Peltonen J, Hsiao LL. Jaakkola S et al, Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-ß 1 mRNA. J Invest Dermatol (1991) 97: 240-8.
  • Reck LS, Chen TL, Hirabayashi SE et al, Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-ß1, Growth Factors (1990) 2: 273-82.
  • Sonis ST, Lindquist L, Van Vugt A et al, Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor ß3, Cancer Res (1994) 54: 1135-8.
  • Kuruvilla AP, Shah R, Hochwald GM et al. Protective effect of transforming growth factor ßl on experimental autoimmune diseases in mice. Proc Natl Acad Sd USA (1991) 88: 2918-21.
  • Massagué J, TGF-beta signal transduction. Annu Rev Biochem (1998) 57: 753-91.
  • McAllister KA, Baldwin MA, Thukkani AK et al, Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet (1995) 4: 1983-4.
  • Hahn SA, Hoque ATMS, Moskaluk CA et al, Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res (1996) 56: 490-4.
  • Markowitz S, Wang J, Myeroff L et al, Inactivation of the type II TGF-ß receptor in colon cancer cells with microsatellite instability. Science (1995) 268: 1336-8.
  • Thiagalingam S, Lengauer C, Leach FS et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 13: 343-6.
  • MacGrogan D, Pegram M, Slamon D, Bookstein R, Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene (1997) 15: 1111-14.
  • Massagué J, Blain SW, Lo RS, TGF-ß signaling in growth control, cancer, and heritable disorders. Cell (2000) 103: 295-309.
  • Roberts AB, Sporn MB, The transforming growth factor-ßs. In: Peptide Growth Factors and Their Receptors, (ed MB Sporn, AB Roberts) Springer, Berlin, 1990 Vol. 1, 419-72.
  • Suardet L, Gaide AC, Calmes JM et al, Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors ßl and ß2. Cancer Res (1992) 52: 3705-12.
  • Cheifetz S, Weatherbee JA, Tsang MLS et al, The transforming growth factor-ß system, a complex pattern of cross-reactive ligands and receptors. Cell (1987) 48: 409-15.
  • Cheifetz S, Bellón T, Calés C et al, Endoglin is a component of the transforming growth factor-ß receptor system in human endothelial cells. J Biol Chem (1992) 267: 19027-30.
  • Cheifetz S, Massagué J, Isoform-specific transforming growth factor-ß binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C. J Biol Chem (1991) 266: 20767-72.
  • Morello JP, Plamondon J, Meyrick B et al, Transforming growth factor-ß receptor expression on endothelial cells: heterogeneity of type III receptor expression. J Cell Physiol (1995) 165: 201-11.
  • Dumont N, O'Connor-McCourt MD, Philip A, Transforming growth factor-ß receptors on human endometrial cells: identification of the type I, II, and III receptors and glycosylphosphatidylinositol anchored TGF-ß binding proteins. Mol Cell Endecrinol (1995) 111: 57-66.
  • O'Connor-McCourt MD, Wakefield LM, Latent transforming growth factor beta in serum. A specific complex with a-2-macroglobulin. J Biol Chem (1987) 262: 14090-9.
  • Crookston KP, Webb DJ, Wolf BB, Gonias SL, Classification of a-2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions. J Biol Chem (1994) 269: 1533-40.
  • Daopin S, Piez KA, Ogawa Y, Davies DR, Crystal structure of transforming growth factor-ß2: an unusual fold for the superfamily. Science (1992) 257: 369-73.
  • Schlunegger MP, Grutter MG, An unusual feature revealed by the crystal structure at 2.2A resolution of human transforming growth factor-ß2. Nature (1992) 358: 430-4.
  • Archer SJ, Bax A, Roberts AB et al. Transforming growth factor ßl: NMR signal assignments of the recombinant protein expressed and isotopically enriched using Chinese hamster ovary cells. Biochemistry (1993) 32: 1152-63.
  • Hinck AP, Archer SJ, Qian SW et al, Transforming growth factor ßl: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor ß2. Biochemistry (1996) 35: 8517-34.
  • Burmester JK, Qian SW, Ohlsen D et al, Mutational analysis of a transforming growth factor-ß receptor binding site. Growth Factors (1998) 15: 231-42.
  • Qian SW, Burmester JK, Tsang MLS et al, Affinity of transforming growth factor-ß to the type II receptor is determined by the C-terminal region of the molecule. J Bial Chem (1996) 271: 30656-62.
  • Qian SW, Dumont N, O'Connor-McCourt MD et al, Distinct functional domains of TGF-beta bind receptors on endothelial cells. Growth Factors (1999) 17: 63-73.
  • Burmester JK, Qian SW, Roberts AB et al, Characterization of distinct functional domains of transforming growth factor-ß. Proc Natl Acad Sci USA (1993) 90: 8628-32.
  • Webb DJ, Atkins TL, Crookston KP et al, Transforming growth factor-ß isoform 2-specific high affinity binding to native a2-macroglobulin. Chimeras identify a sequence that determines affinity for native but not activated 2-macroglobulin. J Biol Chem (1994) 269: 30402-6.
  • Danielpour D, Dart LL, Flanders KC et al, Immunodctection and quantitation of the two forms of transforming growth factor-beta (TGF-ß1 and TGF-ß2) secreted by cells in culture. J Cell Physiol (1989) 138: 79-86.
  • Higuchi R, Krummel B, Saiki RK, A general method of in vitro preparation and specific mutagcnesis of DNA fragments: study of protein and DNA interactions. Nucl Acids Res (1988) 16: 7351-67.
  • Qian SW, Burmester JK, Merwin JR et al, Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor-ß on endothelial cells. Proc Natl Acad Sci USA (1992) 89: 6290-4.
  • Lee SJ, Nathans D, Proliferin secreted by cultured cells binds to manuose 6-phosphate receptors. J Biol Chem (1988) 263: 3521-7.
  • Frolik CA, Wakefield LM, Smith DM, Sporn MB, Characterization of a membrane receptor for transforming growth factor-ß in normal rat kidney fibroblasts. J Biol Chem (1984) 259: 10995-1000.
  • Massagué J, Like B, Cellular receptors for type ß transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem (1985) 260: 2636-45.
  • Geiser AG, Burmester JK, Webbink R et al, Inhibition of growth by transforming growth factor-ß following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. 3 Biol Chem (1992) 267: 2588-93.
  • Tam BYY, Philip A, Transforming growth factor-ß receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phospbatidylinositol-anchored transforming growth faclor-ß binding proteins. } Cell Physiol (1998) 176: 553-64.
  • Qian SW, Burmester JK, Sun PD et al, Characterization of mutated transforming growth factor-ßs which possess unique biological properties. Biochemistry (1994) 33: 12298-304.
  • Huang SS, Liu Q, Johnson FE et al, Transforming growth factor ß peptide antagonists and their conversion to partial agonists. J Biol Chem (1997) 272: 27155-9.
  • Postlethwaite AE, Seyer JM, Identification of a chemotactic epitope in human transforming growth factor-ßl spanning amino acid residues 358-374. J Cell Physiol (1995) 164: 587-92.
  • Stefanova I, Corcoran ML, Horak EM et al, Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/S6lyn. 3 Biol Chem (1993) 208: 20725-8.
  • Lisant MP, Scherer PE, Vidugiriene J et al, Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol (1994) 126: 111-26.
  • Lopez-Casillas F, Wrana JL, Massagué J, Betaglycans presents ligand to the TGF-ß signaling receptor. Cell (1993) 73: 1435-44.
  • Hoodless PA, Wrana JL, Mechanism and function of signaling by the TGF-ß superfamily. Curr Topics Microbiol Immunol (1998) 228: 235-66.
  • Massagué J, Weis-Garcia F, Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv (1996) 27: 41-64.
  • Yamashita H, ten Dijke P, Franzen P et al, Formation of heterooligomeric complexes of type I and type II receptors for transforming growth factor-ß. J Biol Chem (1994) 269: 20171-8.
  • Feng XH, Filvaroff EH, Derynck R, Transforming growth factor-ß (TGF-ß)-induced down-regiuation of cyclin A expression requires a functional TGF-ß receptor complex. J Biol Chem (1995) 270: 24237-45.
  • Tedgui A, Mallat Z, Anti-inflammatory mechanisms in the vascular wall. Circ Res (2001) 88: 877-87.
  • McAllister KA, Grogg KM, Johnson DW et al, Endoglin, a TGF-ß binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet (1994) 8: 345-51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.